Pursuant to provisions of regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby would like to inform you that the Company has made additional investment of USD 2,00,000 to acquire equity shares of Kilitch Estro Biotech PLC, Foreign subsidiary of the Company to meet working capital requirement of the Company